Central Trust Company’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-18
| Closed | -$282 | – | 1440 |
|
2024
Q1 | $282 | Hold |
18
| – | – | ﹤0.01% | 1356 |
|
2023
Q4 | $269 | Buy |
+18
| New | +$269 | ﹤0.01% | 1364 |
|
2023
Q2 | – | Sell |
-20
| Closed | -$1.2K | – | 1273 |
|
2023
Q1 | $1.2K | Hold |
20
| – | – | ﹤0.01% | 1212 |
|
2022
Q4 | $1.47K | Hold |
20
| – | – | ﹤0.01% | 1181 |
|
2022
Q3 | $2K | Hold |
20
| – | – | ﹤0.01% | 1212 |
|
2022
Q2 | $1K | Sell |
20
-100
| -83% | -$5K | ﹤0.01% | 1313 |
|
2022
Q1 | $10K | Buy |
120
+80
| +200% | +$6.67K | ﹤0.01% | 1079 |
|
2021
Q4 | $3K | Sell |
40
-10
| -20% | -$750 | ﹤0.01% | 1177 |
|
2021
Q3 | $6K | Hold |
50
| – | – | ﹤0.01% | 1098 |
|
2021
Q2 | $11K | Sell |
50
-40
| -44% | -$8.8K | ﹤0.01% | 1005 |
|
2021
Q1 | $12K | Sell |
90
-20
| -18% | -$2.67K | ﹤0.01% | 906 |
|
2020
Q4 | $19K | Sell |
110
-40
| -27% | -$6.91K | ﹤0.01% | 812 |
|
2020
Q3 | $17K | Sell |
150
-180
| -55% | -$20.4K | ﹤0.01% | 789 |
|
2020
Q2 | $20K | Hold |
330
| – | – | ﹤0.01% | 743 |
|
2020
Q1 | $22K | Buy |
330
+200
| +154% | +$13.3K | ﹤0.01% | 743 |
|
2019
Q4 | $11K | Hold |
130
| – | – | ﹤0.01% | 934 |
|
2019
Q3 | $10K | Buy |
+130
| New | +$10K | ﹤0.01% | 904 |
|